JP2008516952A5 - - Google Patents

Download PDF

Info

Publication number
JP2008516952A5
JP2008516952A5 JP2007536740A JP2007536740A JP2008516952A5 JP 2008516952 A5 JP2008516952 A5 JP 2008516952A5 JP 2007536740 A JP2007536740 A JP 2007536740A JP 2007536740 A JP2007536740 A JP 2007536740A JP 2008516952 A5 JP2008516952 A5 JP 2008516952A5
Authority
JP
Japan
Prior art keywords
pyrrolidin
ylmethyl
ylmethoxy
fluoro
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007536740A
Other languages
English (en)
Japanese (ja)
Other versions
JP5057982B2 (ja
JP2008516952A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/036023 external-priority patent/WO2006044228A1/en
Publication of JP2008516952A publication Critical patent/JP2008516952A/ja
Publication of JP2008516952A5 publication Critical patent/JP2008516952A5/ja
Application granted granted Critical
Publication of JP5057982B2 publication Critical patent/JP5057982B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007536740A 2004-10-18 2005-10-11 ヒスタミンh3受容体阻害剤、製造及び治療的使用 Expired - Fee Related JP5057982B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61978504P 2004-10-18 2004-10-18
US60/619,785 2004-10-18
PCT/US2005/036023 WO2006044228A1 (en) 2004-10-18 2005-10-11 Histamine h3 receptor inhibitors, preparation and therapeutic uses

Publications (3)

Publication Number Publication Date
JP2008516952A JP2008516952A (ja) 2008-05-22
JP2008516952A5 true JP2008516952A5 (cg-RX-API-DMAC10.html) 2008-10-30
JP5057982B2 JP5057982B2 (ja) 2012-10-24

Family

ID=35677663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007536740A Expired - Fee Related JP5057982B2 (ja) 2004-10-18 2005-10-11 ヒスタミンh3受容体阻害剤、製造及び治療的使用

Country Status (12)

Country Link
US (1) US7846950B2 (cg-RX-API-DMAC10.html)
EP (1) EP1805169B1 (cg-RX-API-DMAC10.html)
JP (1) JP5057982B2 (cg-RX-API-DMAC10.html)
AT (1) ATE418553T1 (cg-RX-API-DMAC10.html)
CY (1) CY1110453T1 (cg-RX-API-DMAC10.html)
DE (1) DE602005011988D1 (cg-RX-API-DMAC10.html)
DK (1) DK1805169T3 (cg-RX-API-DMAC10.html)
ES (1) ES2318565T3 (cg-RX-API-DMAC10.html)
PL (1) PL1805169T3 (cg-RX-API-DMAC10.html)
PT (1) PT1805169E (cg-RX-API-DMAC10.html)
SI (1) SI1805169T1 (cg-RX-API-DMAC10.html)
WO (1) WO2006044228A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008301B2 (en) * 2004-04-01 2011-08-30 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
DE602006010833D1 (de) * 2005-03-17 2010-01-14 Lilly Co Eli Pyrrolidinderivate als histamin-h3-rezeptorantagonisten
SA110310332B1 (ar) 2009-05-01 2013-12-10 Astrazeneca Ab مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل )
EA201291384A1 (ru) 2010-07-06 2013-07-30 Астразенека Аб Терапевтические агенты 976
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2579596B1 (fr) 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
FR2671083B1 (fr) 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
US5652258A (en) 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives
CA2222099A1 (en) 1995-05-30 1996-12-05 Gliatech, Inc. 1h-4(5)-substituted imidazole derivatives
EP0882023B1 (en) 1996-02-09 2003-06-04 James Black Foundation Limited Histamine h 3 receptor ligands
JP2004532834A (ja) 2001-03-23 2004-10-28 イーライ・リリー・アンド・カンパニー ヒスタミンh3受容体アンタゴニストである非イミダゾール系アリールアルキルアミン化合物、その製造および治療的使用
CN1956952B (zh) 2004-06-02 2013-12-11 伊莱利利公司 组胺h3受体药剂、制备和治疗学用途

Similar Documents

Publication Publication Date Title
JP2008510808A5 (cg-RX-API-DMAC10.html)
JP2010533722A5 (cg-RX-API-DMAC10.html)
JP2012522764A5 (cg-RX-API-DMAC10.html)
HRP20160450T1 (hr) Novi inhibitori reduktaze s-nitrozoglutationa
JP2009535358A5 (cg-RX-API-DMAC10.html)
JP2009534470A5 (cg-RX-API-DMAC10.html)
JP2010265321A5 (cg-RX-API-DMAC10.html)
JP2004516314A5 (cg-RX-API-DMAC10.html)
HRP20151405T1 (hr) Novi supstituirani kinolinski spojevi kao inhibitori reduktaze s-nitrosoglutationa
JP2007506740A5 (cg-RX-API-DMAC10.html)
DE502004006218D1 (de) VERFAHREN ZUR HERSTELLUNG EINER FESTEN, ORAL APPLIZIERBAREN PHARMAZEUTISCHEN ZUSAMMENSETZUNG Mit 5-Chlor-N ( ä (5-2-oxo-3- Ä4- (3-oxo-4-morpholinyl)-phenylÜ-1, 3- oxazolidin-5-ylü-methyl)-2-thiophencarboxamid
JP2007530698A5 (cg-RX-API-DMAC10.html)
IL159257A (en) Substituted oxazolidinones for combinational therapy, their preparation and pharmaceutical compositions comprising them
JP2008531599A5 (cg-RX-API-DMAC10.html)
ES2651150T3 (es) Análogos de heterociclilpirimidina como inhibidores de TYK2
JP2011527677A5 (cg-RX-API-DMAC10.html)
NL300370I2 (nl) Gesubstitueerde oxazolidinonen en toepassing daarvan op het terrein van Rivaroxaban, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, hydraat of hydraat van het zout
JP2006500370A5 (cg-RX-API-DMAC10.html)
JP2008525417A5 (cg-RX-API-DMAC10.html)
JP2009534468A5 (cg-RX-API-DMAC10.html)
JP2016006118A5 (cg-RX-API-DMAC10.html)
JP2011503118A5 (cg-RX-API-DMAC10.html)
JP2006526031A5 (cg-RX-API-DMAC10.html)
JP2005532371A5 (cg-RX-API-DMAC10.html)
JP2009525287A5 (cg-RX-API-DMAC10.html)